NewEdge Advisors LLC Reduces Stake in Synopsys, Inc. $SNPS

NewEdge Advisors LLC cut its stake in Synopsys, Inc. (NASDAQ:SNPSFree Report) by 52.1% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 6,521 shares of the semiconductor company’s stock after selling 7,100 shares during the quarter. NewEdge Advisors LLC’s holdings in Synopsys were worth $2,585,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of SNPS. Sankala Group LLC purchased a new position in Synopsys during the fourth quarter worth about $25,000. Caitong International Asset Management Co. Ltd acquired a new position in Synopsys during the fourth quarter worth $28,000. Atlas Capital Advisors Inc. acquired a new position in Synopsys during the 4th quarter worth about $32,000. Phillip James Consulting Co. purchased a new position in shares of Synopsys in the fourth quarter valued at approximately $36,000. Finally, Osbon Capital Management LLC purchased a new position in Synopsys in the 4th quarter valued at approximately $34,000. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Key Synopsys News

Here are the key news stories impacting Synopsys this week:

Insider Buying and Selling

In related news, CFO Shelagh Glaser sold 3,394 shares of the firm’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the completion of the transaction, the chief financial officer directly owned 14,358 shares of the company’s stock, valued at $6,461,387.16. This trade represents a 19.12% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the firm’s stock in a transaction on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the transaction, the chief executive officer owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. This represents a 16.29% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Corporate insiders own 0.56% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the company. Rosenblatt Securities boosted their target price on Synopsys from $530.00 to $575.00 and gave the stock a “buy” rating in a research note on Tuesday, May 26th. Robert W. Baird set a $558.00 price target on shares of Synopsys in a research note on Thursday, May 28th. Citigroup raised their price objective on Synopsys from $600.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, May 28th. Zacks Research raised shares of Synopsys from a “hold” rating to a “strong-buy” rating in a report on Tuesday, June 30th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Synopsys in a report on Monday, June 8th. Two investment analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Synopsys has a consensus rating of “Moderate Buy” and a consensus target price of $565.06.

View Our Latest Stock Report on Synopsys

Synopsys Price Performance

Shares of SNPS opened at $411.75 on Friday. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a twelve month low of $366.00 and a twelve month high of $626.24. The firm has a market capitalization of $78.84 billion, a PE ratio of 95.31, a P/E/G ratio of 2.42 and a beta of 1.23. The stock’s 50 day moving average is $426.49 and its two-hundred day moving average is $443.50.

Synopsys (NASDAQ:SNPSGet Free Report) last released its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.15 by $0.20. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The firm had revenue of $2.28 billion during the quarter, compared to analysts’ expectations of $2.25 billion. During the same quarter in the prior year, the business posted $3.67 earnings per share. Synopsys’s revenue was up 41.9% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Research analysts anticipate that Synopsys, Inc. will post 10.65 earnings per share for the current year.

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Read More

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.